Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Ligand Pharmaceuticals Announces FDA Approval of Ohtuvayre, Increasing Commercial Stage Portfolio to 11 Products; Earns $5.8M Milestone Payment and Anticipates $13.8M Upon Commercial Launch; Entitled to Low Single-Digit Royalty on Global Sales of COPD Treatment

Author: Benzinga Newsdesk | June 27, 2024 08:04am

Posted In: LGND